TABLE 1.
Remission/SU n = 16 |
Allergic n = 16 |
|
---|---|---|
Age (y) | ||
Median (IQR) | 5.8 (4.2–8.7) | 6.3 (3.8–7.9) |
Min–max | 2.1–9.5 | 2.1–10 |
Weight (kg) | ||
Mean (SD) | 23.9 (9.3) | 24.6 (10.2) |
Male sex | ||
n (%) | 12 (75%) | 11 (68.8%) |
History of doctor diagnosed eczema (ever) | ||
n (%) | 12 (75%) | 12 (75%) |
If ever eczema, medication for eczema in last 12 months | ||
n (% of ever eczema) | 9 (75%) | 10 (83.3%) |
History of doctor‐diagnosed asthma (ever) | ||
n (%) | 7 (43.8%) | 8 (50%) |
If ever asthma, medication for asthma in last 12 months | ||
n (% of asthma ever) | 6 (85.7%) | 8 (100%) |
History of anaphylaxis to peanut* | ||
n (%) | 5 (31.2%) | 6 (37.5%) |
Peanut‐specific SPT wheal size (mm) | ||
Mean (SD) | 16.6 (5.4) | 17.6 (7.3) |
sIgE (kU/L) | ||
Median (IQR) | 4.7 (0.9–56.5) | 11.7 (2.8–62) |
Abbreviations: IQR, interquartile range; SD, standard deviation; kU/L, kilo unit per liter.
*One missing in the placebo group.